Fig. 2From: Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcomeProportions decisions and sample size along the interim and terminal analyses when K=2. n=800,π=0.5 and qB=qA=0.5. IA= Interim analysis, TA= Terminal analysisBack to article page